Optimising lung surfactant protein production in the IUGR fetus at risk of preterm delivery

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1030853

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Pregnant women at risk of preterm labour after 24 weeks gestation are increasingly administered glucocorticoids in Australian hospitals in order to promote fetal lung maturation and a successful transition to extrauterine life. Antenatal glucocorticoid treatment reduces overall neonatal mortality, the risk of respiratory distress syndrome and the need for respiratory support. Babies that are born small may not benefit from this treatment in the same way that average size babies benefit.

Funded Activity Details

Start Date: 01-01-2012

End Date: 01-01-2014

Funding Scheme: Project Grants

Funding Amount: $463,853.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Systems Physiology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

glucocorticoids | hypoxaemia | intrauterine growth restriction | lung surfactant | respiratory distress syndrome (RDS)

Related Links